Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: The objective of this study was to investigate the association between nonalcoholic fatty liver disease (NAFLD)and carotid artery atherosclerosis beyond metabolic disorders. Methods: We studied 320 non-diabetic patients with ultrasonographically diagnosed NAFLD and 313 non-diabetic patients without NAFLD who have less than 40 g alcohol/week drinking history. Carotid atherosclerotic burden was assessed by carotid intima-media thickness (IMT) and plaque. All subjects were divided to the metabolic syndrome (MetS) according to International Diabetes Federation criteria. Results: NAFLD patients had a significantly increased mean carotid IMT (0.79 ± 0.18 vs. 0.73 ± 0.13 mm; p < 0.001) than those without the condition. The prevalence of increased IMT, defined as IMT ≥ 1 mm, and carotid plaque were 52.5% and 34.1% in the patients with NAFLD vs. 35.8% and 18.8% in the patients without this condition (p < 0.001). The difference in IMT and prevalence of plaque was also significant even in patients without MetS as well as those with MetS (all p < 0.05). NAFLD-associated adjusted odds ratio for increased IMT was 1.236 [95% confidence interval (CI), 1.023-1.467, p = 0.016]without MetS and 1.178 (95% CI, 1.059-1.311, p = 0.003) with MetS. NAFLD-associated adjusted odds ratio of carotid plaque was 1.583 (95% CI, 1.309-1.857, p = 0.024) without MetS and 1.536 (95% CI, 0.512-4.604, p = 0.444) with MetS. Conclusion: NAFLD is significantly associated with carotid atherosclerosis in non-diabetic outpatients even without MetS. Carotid screening for NAFLD might be beneficial for assessment of future atherosclerotic complications.
Abstract
Background: The objective of this study was to investigate the association between nonalcoholic fatty liver disease (NAFLD)and carotid artery atherosclerosis beyond metabolic disorders. Methods: We studied 320 non-diabetic patients with ultrasonographically diagnosed NAFLD and 313 non-diabetic patients without NAFLD who have less than 40 g alcohol/week drinking history. Carotid atherosclerotic burden was assessed by carotid intima-media thickness (IMT) and plaque. All subjects were divided to the metabolic syndrome (MetS) according to International Diabetes Federation criteria. Results: NAFLD patients had a significantly increased mean carotid IMT (0.79 ± 0.18 vs. 0.73 ± 0.13 mm; p < 0.001) than those without the condition. The prevalence of increased IMT, defined as IMT ≥ 1 mm, and carotid plaque were 52.5% and 34.1% in the patients with NAFLD vs. 35.8% and 18.8% in the patients without this condition (p < 0.001). The difference in IMT and prevalence of plaque was also significant even in patients without MetS as well as those with MetS (all p < 0.05). NAFLD-associated adjusted odds ratio for increased IMT was 1.236 [95% confidence interval (CI), 1.023-1.467, p = 0.016]without MetS and 1.178 (95% CI, 1.059-1.311, p = 0.003) with MetS. NAFLD-associated adjusted odds ratio of carotid plaque was 1.583 (95% CI, 1.309-1.857, p = 0.024) without MetS and 1.536 (95% CI, 0.512-4.604, p = 0.444) with MetS. Conclusion: NAFLD is significantly associated with carotid atherosclerosis in non-diabetic outpatients even without MetS. Carotid screening for NAFLD might be beneficial for assessment of future atherosclerotic complications.
참고문헌 (35)
- Park SH, "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 21, pp.138~143 (2006), BLACKWELL PUBLISHING
- 최수연, "심혈관계 위험인자로서의 비알코올지방간질환; 경동맥 동맥경화와의 상관관계", Clinical and Molecular Hepatology, 14(1), pp.77~88 (2008), 대한간학회
- Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
- Adams LA, "Recent concepts in non-alcoholic fatty liver disease", Diabet Med, 22, pp.1129~1133 (2005)
- McCullough AJ, "The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease", Clin Liver Dis, 8, pp.521~533 (2004)
- Targher G, "Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation", Diabetes Care, 27, pp.2498~2500 (2004)
- Aygun C, "Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease", Dig Dis Sci, 53, pp.1352~1357 (2008)
- Targher G, "Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients", Diabetes Care, 30, pp.2119~2121 (2007)
- Musso G, "Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects", Diabetes Care, 31, pp.562~568 (2008)
- Marchesini G, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome", Diabetes, 50, pp.1844~1850 (2001)
- 김현창, "Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome", Atherosclerosis, 204(2), pp.521~525 (2009), ELSEVIER IRELAND LTD
- 정진원, "동맥경화의 진단방법으로 경동맥 내막-중막 두께의 의의", Journal of Cardiovascular Ultrasound, 10(2), pp.8~12 (2002), 한국심초음파학회
- O’Leary DH, "Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group", N Engl J Med, 340, pp.14~22 (1999)
- 박병현, "관상동맥 질환의 유무와 심한정도를 예측하는데 있어 경동맥 내막-중막 두께와 죽상경화반의 의의", Journal of Cardiovascular Ultrasound, 8(1), pp.45~53 (2000), 한국심초음파학회
- Volzke H, "Hepatic steatosis is associated with an increased risk of carotid atherosclerosis", World J Gastroenterol, 11, pp.1848~1853 (2005)
- "International Diabetes Federation Press Conference. The IDF consensus worldwide definition of the metabolic syndrome" (2006)[URL]
- Korean Society for the Study of Obesity, "Report on cut-off point of body mass index and waist circumference for criteria of obesity and abdominal obesity among Korean. In Proceedings of the Symposium for Criteria of Obesity and Abdominal Obesity Among Korean", Korean Society for the Study of Obesity, pp.2~3 (2005)
- Sanyal AJ, "American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease", Gastroenterology, 123, pp.1705~1725 (2002)
- Palmentieri B, "The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis", Dig Liver Dis, 38, pp.485~489 (2006)
- Vermeersch SJ, "Validation of a new automated IMT measurement algorithm", J Hum Hypertens, 21, pp.976~978 (2007)
- Barth JD, "An update on carotid ultrasound measurement of intima-media thickness", Am J Cardiol, 89, pp.32~39 (2002)
- Pacifico L, "Nonalcoholic fatty liver disease and carotid atherosclerosis in children", Pediatr Res, 63, pp.423~427 (2008)
- Petit JM, "Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients", J Clin Endocrinol Metab, 94, pp.4103~4106 (2009)
- Targher G, "Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients", J Endocrinol Invest, (29), pp.55~60 (2006)
- Wannamethee G, "Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes", Am J Epidemiol, 142, pp.699~708 (1995)
- Jousilahti P, "Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke", Stroke, 31, pp.1851~1855 (2003)
- Brea A, "Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study", Arterioscler Thromb Vasc Biol, 25, pp.1045~1050 (2005)
- Nannipieri M, "Mexico City diabetes study. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study", Diabetes Care, 28, pp.1757~1762 (2005)
- Hanley AJ, "Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study", Diabetes, 54, pp.3140~3147 (2005)
- Stefan N, "Causes and metabolic consequences of Fatty liver", Endocr Rev, 29, pp.939~960 (2008)
- Villanova N, "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease", Hepatology, 42, pp.473~480 (2005)
- Schindhelm RK, "Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus", Eur J Clin Invest, 35, pp.369~374 (2005)
- Neuschwander-Tetri BA, "Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference", Hepatology, 37, pp.1202~1219 (2003)
- Saadeh S, "The utility of radiological imaging in nonalcoholic fatty liver disease", Gastroenterology, 123, pp.745~750 (2002)
- Hernaez R, "Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis", Hepatology, 54, pp.1082~1090 (2011)
